The German Haemovigilance System–reports of serious adverse transfusion reactions between 1997 and 2007
Authors:
- 4 November 2009
- journal article
- Published by Wiley in Transfusion Medicine
- Vol. 19 (6) , 340-349
Abstract
Summary.: Data of the German Haemovigilance System were collected from 1997 to 2007 and assessed on the basis of pre‐defined safety standards. Suspected cases of serious adverse reactions following transfusions reported to the Paul‐Ehrlich‐Institut were evaluated on the basis of national criteria, and the definitions of International Society of Blood Transfusion (ISBT) in compliance with defined causality criteria. The suspected cases were rated as confirmed and unconfirmed transfusion reactions. Assessment of causality took into consideration the clinical course of the adverse reaction and, if necessary, information about donation and manufacturing. Of the 5128 suspected serious adverse reactions, 1603 could be confirmed. Referring to the absolute figures, acute transfusion reactions (e.g. allergic reactions, hypotension and dyspnoea) were recorded most frequently, followed by transfusion‐related acute lung injury (TRALI), haemolytic reactions, transfusion‐related bacterial infections and virus infections. The majority of the 52 transfusion‐related fatalities (14 each) were due to TRALI and acute transfusion reactions (mostly severe allergic reactions). Referred to the blood products administered, immune TRALI cases and TRALI‐related fatal courses were most frequently reported after administration of fresh frozen plasma (FFP) (15/106 and 3.5/106 units, respectively), transfusion‐related bacterial infections after administration of platelet concentrates (7/106 units), acute haemolytic transfusion reactions after administration of red blood cell concentrates (2.3/106units) and acute transfusion reactions after administration of red blood cell or platelet concentrates (7.8/106 and 13/106 units, respectively). Despite the high safety standard required for blood products in Germany, there is still room for reducing the frequency of isolated cases of transfusion reactions by targeted action.Keywords
This publication has 11 references indexed in Scilit:
- Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissionsTransfusion, 2009
- Ten years of hemovigilance reports of transfusion‐related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasmaTransfusion, 2009
- Specificities of leucocyte alloantibodies in transfusion‐related acute lung injury and results of leucocyte antibody screening of blood donorsVox Sanguinis, 2008
- Demography and donation frequencies of blood and plasma donor populations in GermanyBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2008
- Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004‐2006)Transfusion, 2007
- Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood–derived platelets and apheresis plateletsTransfusion, 2007
- Serious Hazards of Transfusion: A Decade of Hemovigilance in the UKTransfusion Medicine Reviews, 2006
- The French Haemovigilance System: organization and results for 2003Transfusion and Apheresis Science, 2004
- Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998Transfusion, 2002
- Causality assessment of suspected virustransmission by human plasma productsTransfusion, 2001